Optispring (Tetryzoline Hydrochloride)

Tetryzoline Hydrochloride, the active ingredient in Optispring, is an alpha‑adrenergic agonist presented as an ophthalmic solution for ocular use. It reduces conjunctival redness and alleviates eye irritation in adults and children when applied as directed. It is available without prescription in the European Union and is intended for short‑term relief of transient ocular redness.

GNH USA supplies Optispring as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for importers.

Tetryzoline Hydrochloride is an ocular decongestant that acts on conjunctival blood vessels to reduce redness.

- Ocular redness: provides rapid reduction of visible redness in the white of the eye. - Conjunctival hyperemia: diminishes blood‑vessel dilation for a clearer appearance. - Eye irritation: alleviates discomfort associated with minor irritants. - Allergic conjunctivitis: offers temporary relief of redness linked to mild allergic reactions.

Common Side Effects: - Stinging or burning sensation: mild discomfort upon instillation. - Transient blurred vision: temporary focus changes that resolve quickly. - Eye dryness: reduced tear film leading to dryness. - Mild eyelid edema: slight swelling around the eyelid.

Serious or Rare Side Effects: - Allergic conjunctivitis: severe redness, swelling, and itching requiring discontinuation. - Corneal ulceration: rare but serious corneal damage. - Significant intraocular pressure rise: may exacerbate glaucoma.

Use Optispring only as directed and consider the following precautions. - Hypersensitivity: avoid use in patients with known allergy to tetryzoline or related compounds. - Frequency limit: do not exceed recommended dosing to prevent rebound hyperemia. - Glaucoma caution: use with care in patients with narrow‑angle glaucoma. - Contact lens wearers: remove lenses before application to reduce irritation. - Pregnancy and breastfeeding: safety not established; consult a healthcare professional before use. - Store at room temperature: keep in the original container, protect from light and moisture.

Tetryzoline may interact with other agents; monitor the following.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may potentiate vasoconstrictive effects. - Other ocular vasoconstrictors (e.g., naphazoline): risk of additive vasoconstriction. - Systemic sympathomimetics (e.g., pseudoephedrine): potential cardiovascular effects.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask signs of infection. - Contact lens solutions containing preservatives: may increase ocular irritation. - Antihistamine eye drops: possible additive dryness.